Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mako Surgical knee surgery robot gains 510(k) clearance

This article was originally published in The Gray Sheet

Executive Summary

Launch in the first half of 2009 of the firm's RIO Tactile Guidance System version 2.0 robotic-arm and Restoris MCK bicompartmental knee resurfacing implant is planned by the company following receipt of two related 510(k) clearances, announced Dec. 2. The Ft. Lauderdale, Fla., firm launched version 1.0 of the system in 2006 for unicompartmental knee procedures and went public in February. The Tactile Guidance System, previously referred to as the Haptic Guidance System, incorporates patient-specific visualization to help prepare the knee joint for minimally invasive placement of resurfacing implants (1"The Gray Sheet" Oct. 22, 2007, p. 17)

You may also be interested in...



Financings In Brief

Mako Surgical offering nets $54.4 million: Robotic knee surgery device maker Mako Surgical nets $54.4 million from a secondary offering of 8.05 million shares of common stock at $7.25 each, completed Aug. 19. The proceeds are tabbed "to support commercialization, sales, marketing and general administrative activities" as well as R&D and working capital, the company explains. In February, the firm rolled out its "next generation" RIO Tactile Guidance System version 2.0 robotic arm and Restoris MCK bi-compartmental knee resurfacing implant. The Fort Lauderdale, Fla., firm, which previously offered versions of the technology for unicompartmental knee procedures, went public in February 2008 (1"The Gray Sheet" Dec. 8, 2008). Underwriters for the most recent offering are Piper Jaffray & Co. and Leerink Swann LLC

IPO: Mako Surgical Seeks Funds To Boost Robotic Knee Resurfacing Efforts

Mako Surgical is proposing an initial public stock offering valued at up to $86.3 million to aid its development of the Haptic Guidance System version 2.0 for robotic, multicompartmental knee resurfacing procedures (see chart: "1Mako Surgical IPO")

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel